Home Cart 0 Sign in  
X

[ CAS No. 78888-18-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 78888-18-3
Chemical Structure| 78888-18-3
Chemical Structure| 78888-18-3
Structure of 78888-18-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 78888-18-3 ]

Related Doc. of [ 78888-18-3 ]

Alternatived Products of [ 78888-18-3 ]

Product Details of [ 78888-18-3 ]

CAS No. :78888-18-3 MDL No. :MFCD00191870
Formula : C8H15NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :AWARHXCROCWEAK-UHFFFAOYSA-N
M.W : 157.21 Pubchem ID :4067274
Synonyms :

Calculated chemistry of [ 78888-18-3 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.62
Num. rotatable bonds : 5
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 44.61
TPSA : 38.33 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.14 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.43
Log Po/w (XLOGP3) : 1.57
Log Po/w (WLOGP) : 1.7
Log Po/w (MLOGP) : 1.38
Log Po/w (SILICOS-IT) : 0.89
Consensus Log Po/w : 1.59

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.47
Solubility : 5.28 mg/ml ; 0.0336 mol/l
Class : Very soluble
Log S (Ali) : -1.99
Solubility : 1.63 mg/ml ; 0.0103 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.67
Solubility : 3.37 mg/ml ; 0.0214 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.2

Safety of [ 78888-18-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P264-P270-P301+P312-P330-P501 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 78888-18-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 78888-18-3 ]
  • Downstream synthetic route of [ 78888-18-3 ]

[ 78888-18-3 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 78888-18-3 ]
  • [ 123-73-9 ]
  • [ 5176-27-2 ]
Reference: [1] Synlett, 2011, # 1, p. 124 - 128
  • 2
  • [ 78888-18-3 ]
  • [ 58885-58-8 ]
Reference: [1] Synthetic Communications, 1995, vol. 25, # 14, p. 2135 - 2143
  • 3
  • [ 24424-99-5 ]
  • [ 107-11-9 ]
  • [ 78888-18-3 ]
YieldReaction ConditionsOperation in experiment
96% at 80℃; for 0.166667 h; Green chemistry General procedure: The reactions were carried out in a 50 mL RB flask under reduced pressure for 10 min at 80°C unless reported differently. In a typical experiment, 5 mmol of amine was added to 5 mmol of BOC anhydride, and the reaction was allowed to proceed for 10 min. The desired product was obtained in a rotary evaporator under vacuum conditions.
91% With triethylamine In dichloromethane at 0 - 20℃; for 5.5 h; To a solution of compound 144 (8.80 g, 154.1 mmol) in CH2Cl2 (150 mL) was added TEA (32.2 mL, 231.2 mmol) and Boc2O (40.4 g, 185.3 mmol) at 0° C. The reaction mixture was continued to be stirred at 0° C. for 0.5 h, allowed to be warmed to room temperature and stirred for 5 h. Then the mixture was partitioned between CH2Cl2 (150 mL) and water (150 mL). The aqueous layer was separated and extracted with CH2Cl2 (2×150 mL). The combined organic extracts were washed with brine, dried over Na2SO4, concentrated to afford desired compound 145 (22.0 g, 91percent) as a colorless oil. 1H NMR (400 MHz, CDCl3): δ 5.90-5.77 (m, 1H), 5.17 (dq, J=17.1, 1.7 Hz, 1H), 5.10 (dq, J=10.4, 1.4 Hz, 1H), 4.64 (brs, 1H), 3.74 (t, J=5.2 Hz, 2H), 1.45 (s, 9H).
84.74% at 0 - 20℃; for 4 h; Example 235. Synthesis of 3-fluoro-2-(4-(6-hydroxy-4,5,6,7- tetrahydropyrazolo [1 ,5-a] pyrimidin-2-yl)-5-oxo-6,7-dihydro-5H-pyrrolo [3,4-b] pyridin-2- yl)benzonitrile 1-235 Synthesis of compound 235.2. To a solution of prop-2-en-l -amine (15.0g, 263mmol, 1.0 eq) in DCM (300mL) was added di-tert-butyl dicrabonate (57.3g, 263mmol, l.Oeq) at 0 °C. Reaction mixture was stirred at room temperature for 4 h. Upon completion of reaction; reaction mixture was washed with 5percent citric acid solution followed by brine. Organic layer was dried over Na2S04 and concentrated under reduced pressure to pressure to obtain pure 235.2 (35g, 84.74percent).
81% With N-ethyl-N,N-diisopropylamine In tetrahydrofuran for 1 h; Inert atmosphere General procedure: To a solution of allylamine (6; 3.0 mL, 39.8 mmol) in THF (20 mL) was added i-Pr2NEt (13 mL, 80.0 mmol) and Boc2O (9.0 mL, 39.9 mmol).After stirring 1 h, the reaction mixture was diluted with Et2O (50 mL),the organic layer was separated, and washed with sat. aq NH4Cl(3 × 20 mL), H2O (20 mL) and brine (20 mL), dried (Na2SO4), pouredover a silica gel plug, and concentrated under reduced pressure. Purification by flash column chromatography (hexanes–EtOAc, 90:10) delivered the corresponding Boc-allylamine (5.16 g, 81percent) as a clear oil.To a solution of this Boc-allylamine (2.60 g, 16.4 mmol) in p-xylene(16 mL) was added dioxinone 43(3.6 mL, 24.7 mmol). The reactionmixture was heated to reflux (150 °C) for 1.5 h, then allowed to coolto 23 °C, and concentrated under reduced pressure. Purification byflash column chromatography (hexanes–EtOAc, 80:20) delivered thecorresponding β-keto amide (2.35 g, 59percent) as a yellow oil. To a solutionof this β-keto amide (2.66 g, 11.0 mmol) in MeCN (55 mL) was addedp-ABSA (4.01 g, 16.5 mmol) and Et3N (6.2 mL, 44.1 mmol) at 0 °C. Thereaction was allowed to warm to 23 °C and stirred for 16 h. The mixture was concentrated and triturated with hexanes–EtOAc (1:1),poured over silica gel, and concentrated under reduced pressure. Purification by flash column chromatography (hexanes–EtOAc, 80:20) delivered 38bas a yellow oil; yield: 2.45 g (83percent)
80% With triethylamine In dichloromethane at 0 - 20℃; for 12 h; To a suspension of ally amine (2.0 g, 35.08 mmol) in dichloromethane was added Bocanhydride (8.4 g, 38.59 mmol), followed by triethylamine (5.3 g, 52.63 mmol) at 0 °C. The resulting reaction mixture was stirred at room temperature for 12 h. The reactionmixture was evaporated under reduced pressure to give the residue. Residue was purified by column chromatography on silica gel (hexanes/ethyl acetate =hexanes/ ethyl acetate =90/10) to give the titled compound (2.2 g, 80 percent) as a liquid.
80% With 1H-imidazole In ethanol at 20℃; Allylamine (0.75 mL, 10.02 mmol), abs. EtOH (50 mL), and B0C2O (2.40 g, 1 1.00 mmol) were stirred at room temperature under air until the effervescence subsided. Imidazole (0.81 g, 1 1.90 mmol) was then added and the reactioncontinued at room temperature under air for 1 h. The reaction was then concentrated in vacuo. The crude residue was purified via MPLC (silica, 10-20percent hexanes/EtOAc) to provide KSC-288- 055-1 (1.2637 g, 8.04 mmol, 80 percent yield). lR NMR (500 MHz, Chloroform-d) δ 5.82 (ddt, J = 15.8, 10.6, 5.4 Hz, 1H), 5.15 (dq, J = 17.2, 1.6 Hz, 1H), 5.08 (dq, J = 10.3, 1.4 Hz, 1H), 4.73 (s, 1H), 3.79-3.60 (m, 2H), 1.43 (s, 9H); 13C NMR (126 MHz, CDC13) δ 155.77, 134.91, 115.59, 79.25, 43.02, 28.36; HRMS (ESI-TOF) m/z: [M - C5H902 + 2H]+ Calcd for C3H8N 58.0651; Found 58.0661
68% at 0 - 20℃; for 4 h; Synthesis of tert-Butyl N-allylcarbamate (3)
Tert-butyl N-allylcarbamate was synthesised according to the method of Rocheblave (30).
2.3 mL (30 mmol, 1 equiv) of freshly distilled allylamine 2 in 10 mL CH2Cl2 was cooled in an ice bath (0° C.).
To this cold solution was added 6.54 g Boc2O (30 mmol, 1 equiv) in 20 mL CH2Cl2.
The solution was brought to room temperature and stirred for 4 hours.
The reaction mixture was then diluted with additional CH2Cl2 and washed with 5percent citric acid solution followed by brine.
The organic layer was dried over Na2SO4 and concentrated in vacuo, yielding 3.29 g (68percent yield) of 3.
1H NMR (500 MHz, CDCl3): δ1.38 (s, 9H), 3.68 (brs, 2H), 4.53 (brs, 1H), 5.02-5.16 (m, 2H), 5.72-5.84 (m, 1H).
68% at 20℃; for 4 h; Cooling with ice Freshly-distilled allylamine (2.3 mL, 30 mmol, 1 eq) and 10 mL of anhydrous CH2Cl2 were combined and cooled in an ice bath. Di-tert-butyl dicarbonate (6.54 g, 30.0 mmol, 1.00 eq) in 20 mL anhydrous CH2Cl2 was added, and the mixture was stirred at room temperature for 4 h. The reaction mixture was diluted with additional CH2Cl2 and washed with 5percent citric acid solution, followed by brine. The organic layer was dried over Na2SO4 and concentrated under reduced pressure to afford 3.3 g of tert-butyl allylcarbamate 9 with a yield of 68percent. 1H NMR (400 MHz, CDCl3):δ 5.90-5.81 (m, 1H, NH), 5.24-4.96 (m, 2H, =CH2), 4.63 (s, 1H, =CH), 3.75 (s, 2H, CH2), 1.45 (s, 9H, CH3).
58% at 0 - 20℃; for 1 h; A solution of 5.88 ml (27.5 mmol, 1.1 eq.) of Boc2O in 50 ml of dry CH2Cl2 was addeddropwise to a solution of 1.88 ml (25.0 mmol, 1.0 eq.) of allyl amine in 60 ml of dry CH2Cl2at 0°C. The reaction mixture was stirred at r.t. for 1 h. After TLC showed completeconsumption of starting material, solvent was removed under reduced pressure. The crudeproduct was purified by flash column chromatography (cHex/EtOAc 12:1). The product wasobtained as a light yellow solid (yield: 2.26 g, 14.395 mmol, 58 percent).

Reference: [1] Tetrahedron Letters, 2007, vol. 48, # 35, p. 6163 - 6166
[2] Angewandte Chemie - International Edition, 2014, vol. 53, # 41, p. 11075 - 11078
[3] Tetrahedron Letters, 1998, vol. 39, # 15, p. 2099 - 2102
[4] Journal of the Chemical Society. Perkin Transactions 1, 2001, # 16, p. 1916 - 1928
[5] Tetrahedron Letters, 2009, vol. 50, # 46, p. 6244 - 6246
[6] Journal of Organic Chemistry, 1998, vol. 63, # 26, p. 9904 - 9909
[7] Journal of Organic Chemistry, 2006, vol. 71, # 21, p. 8283 - 8286
[8] Journal of Medicinal Chemistry, 2002, vol. 45, # 15, p. 3321 - 3324
[9] Chemistry - A European Journal, 2016, vol. 22, # 35, p. 12274 - 12277
[10] Research on Chemical Intermediates, 2017, vol. 43, # 3, p. 1355 - 1363
[11] Tetrahedron, 2007, vol. 63, # 21, p. 4472 - 4490
[12] Tetrahedron Letters, 2009, vol. 50, # 23, p. 2716 - 2718
[13] Patent: US5534542, 1996, A,
[14] Journal of the American Chemical Society, 2006, vol. 128, # 50, p. 16323 - 16331
[15] Bulletin of the Chemical Society of Japan, 2009, vol. 82, # 12, p. 1520 - 1527
[16] ACS Combinatorial Science, 2013, vol. 15, # 7, p. 344 - 349
[17] Synthetic Communications, 1995, vol. 25, # 14, p. 2135 - 2143
[18] Journal of Organic Chemistry, 1988, vol. 53, # 15, p. 3457 - 3465
[19] Patent: US2014/171447, 2014, A1, . Location in patent: Paragraph 0427; 0428
[20] Polish Journal of Chemistry, 2006, vol. 80, # 6, p. 907 - 912
[21] Tetrahedron, 1990, vol. 46, # 6, p. 1975 - 1986
[22] Journal of Organic Chemistry, 2011, vol. 76, # 19, p. 7737 - 7749
[23] Patent: WO2017/40757, 2017, A1, . Location in patent: Paragraph 001058-001059
[24] Tetrahedron, 2009, vol. 65, # 24, p. 4751 - 4765
[25] Journal of Medicinal Chemistry, 1984, vol. 27, # 6, p. 711 - 712
[26] Synthesis (Germany), 2015, vol. 47, # 18, p. 2756 - 2766
[27] Patent: WO2014/111871, 2014, A1, . Location in patent: Page/Page column 29
[28] Patent: WO2014/201016, 2014, A2, . Location in patent: Paragraph 00169
[29] MedChemComm, 2015, vol. 6, # 5, p. 919 - 925
[30] Chemical Communications, 2017, vol. 53, # 26, p. 3713 - 3716
[31] Patent: US2008/312440, 2008, A1, . Location in patent: Page/Page column 9
[32] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 4, p. 949 - 954
[33] Synlett, 2018, vol. 29, # 6, p. 785 - 792
[34] Organic and Biomolecular Chemistry, 2005, vol. 3, # 12, p. 2333 - 2343
[35] Journal of Heterocyclic Chemistry, 1990, vol. 27, # 7, p. 2077 - 2079
[36] Liebigs Annalen der Chemie, 1989, p. 985 - 990
[37] Recueil des Travaux Chimiques des Pays-Bas-Journal of the Royal Netherlands, 1996, vol. 115, # 1, p. 13 - 19
[38] Tetrahedron Letters, 1999, vol. 40, # 22, p. 4173 - 4176
[39] Patent: US5220047, 1993, A,
[40] Patent: EP237082, 1991, B1,
[41] Journal of Organic Chemistry, 2008, vol. 73, # 22, p. 8987 - 8991
[42] Patent: EP1203767, 2002, A1, . Location in patent: Page 68
[43] Chemistry - A European Journal, 2012, vol. 18, # 18, p. 5589 - 5605
[44] Tetrahedron Letters, 2014, vol. 55, # 19, p. 3041 - 3044
[45] Tetrahedron, 2015, vol. 71, # 4, p. 554 - 559
[46] Patent: WO2016/149628, 2016, A1, . Location in patent: Paragraph 000140
[47] Heterocycles, 2017, vol. 95, # 2, p. 994 - 1029
[48] Organic Letters, 2017, vol. 19, # 1, p. 86 - 89
  • 4
  • [ 92136-39-5 ]
  • [ 78888-18-3 ]
YieldReaction ConditionsOperation in experiment
63%
Stage #1: With n-butyllithium; copper(l) cyanide In tetrahydrofuran at -78℃; for 0.25 h;
Stage #2: With tri-n-butyl-tin hydride In tetrahydrofuran at -78℃; for 0.333333 h;
Stage #3: at -78℃; for 1 h;
A solution of copper cyanide (1.1Sg, 12.9 mmol) in THF (30 mL) at ?78 C. was treated slowly with n-butyllithium (16.9 mL, 27.1 mmol), stirred for 15 minutes at ?78 C., treated with tributyltin hydride (7.88 g, 7.30 mL, 27.1 mmol) over a period of 5 minutes, stirred for 15 minutes, treated with tert-butyl 2-propynylcarbamate (2.00 g, 12.9 mmol) in tetrahydrofuran (7 mL), stirred at ?780C for 1 hour, and treated with a 9:1 aqueous solution of ammonium chloride:ammonium hydroxide (250 mL) and dichloromethane (200 mL). The suspension was filtered through a short pad of diatomaceous earth (Celite). The organic phase of the filtrate was washed with brine and concentrated. The residue was purified on silica gel using 1-2percent ethyl acetate/heptane to provide the desired product (3.66 g, 63percent). 1H NMR (400 MHz, CDCl3) ? 6.08 (dt, B part of an AB system, J=19.3 Hz, 1.3 Hz, 1H); 5.93 (dt, A part of an AB system, J=19.3 Hz, 4.8 Hz, 1H), 4.59 (br s, 1H), 3.78 (br s, 2H), 1.45 (s, 9H), 1.32-1.26, (m, 12H), 0.90-0.85 (m, 15H).
63% With ammonium hydroxide; n-butyllithium; ammonium chloride; tri-n-butyl-tin hydride In tetrahydrofuran; n-heptane; dichloromethane; ethyl acetate EXAMPLE 314A
tert-butyl allylcarbamate
A solution of copper cyanide (1.15 g, 12.9 mmol) in THF (30 mL) at -78° C. was treated slowly with n-butyllithium (16.9 mL, 27.1 mmol), stirred for 15 minutes at -78° C., treated with tributyltin hydride (7.88 g, 7.30 mL, 27.1 mmol) over a period of 5 minutes, stirred for 15 minutes, treated with tert-butyl 2-propynylcarbamate (2.00 g, 12.9 mmol) in tetrahydrofuran (7 mL), stirred at -78° C. for 1 hour, and treated with a 9:1 aqueous solution of ammonium chloride:ammonium hydroxide (250 mL) and dichloromethane (200 mL).
The suspension was filtered through a short pad of diatomaceous earth (Celite.(R).).
The organic phase of the filtrate was washed with brine and concentrated.
The residue was purified on silica gel using 1-2percent ethyl acetate/heptane to provide the desired product (3.66 g, 63percent).
1H NMR (400 MHz, CDCl3) δ 6.08 (dt, B part of an AB system, J=19.3 Hz, 1.3 Hz, 1H); 5.93 (dt, A part of an AB system, J=19.3 Hz, 4.8 Hz, 1H), 4.59 (br s, 1H), 3.78 (br s, 2H), 1.45 (s, 9H), 1.32-1.26, (m, 12H), 0.90-0.85 (m, 15H).
63%
Stage #1: With n-butyllithium; copper(I) cyanide In tetrahydrofuran at -78℃; for 0.25 h;
Stage #2: With tri-n-butyl-tin hydride In tetrahydrofuran for 0.333333 h;
tert-butyl allylcarbamate
A solution of copper cyanide (1.15 g, 12.9 mmol) in THF (30 mL) at -78° C. was treated slowly with n-butyllithium (16.9 mL, 27.1 mmol), stirred for 15 minutes at -78° C., treated with tributyltin hydride (7.88 g, 7.30 mL, 27.1 mmol) over a period of 5 minutes, stirred for 15 minutes, treated with tert-butyl 2-propynylcarbamate (2.00 g, 12.9 mmol) in tetrahydrofuran (7 mL), stirred at -78° C. for 1 hour, and treated with a 9:1 aqueous solution of ammonium chloride:ammonium hydroxide (250 mL) and dichloromethane (200 mL).
The suspension was filtered through a short pad of diatomaceous earth (Celite.(R).).
The organic phase of the filtrate was washed with brine and concentrated.
The residue was purified on silica gel using 1-2percent ethyl acetate/heptane to provide the desired product (3.66 g, 63percent).
1H NMR (400 MHz, CDCl3) δ 6.08 (dt, B part of an AB system, J=19.3 Hz, 1.3 Hz, 1H); 5.93 (dt, A part of an AB system, J=19.3 Hz, 4.8 Hz, 1H), 4.59 (br s, 1H), 3.78 (br s, 2H), 1.45 (s, 9H), 1.32-1.26, (m, 12H), 0.90-0.85 (m, 15H).
Reference: [1] Chemical Communications, 2015, vol. 51, # 12, p. 2384 - 2387
[2] Patent: US2005/20619, 2005, A1, . Location in patent: Page 58-59
[3] Patent: US2005/26944, 2005, A1,
[4] Patent: US2005/43347, 2005, A1, . Location in patent: Page/Page column 67-68
  • 5
  • [ 41840-28-2 ]
  • [ 107-11-9 ]
  • [ 78888-18-3 ]
YieldReaction ConditionsOperation in experiment
85.5% With hydrogenchloride In chloroform 1)
Synthesis of N-t-butoxycarbonylallylamine (27)
Allylamine [2.855 g (50 mmol.)] was dissolved in chloroform (100 m), to which was added t-butyl S-(4,6-dimethylpyrimidin-2-yl)thiocarbonate [12.017 g (50 mmol.)], and then the mixture was stirred at room temperature for 24 hours. 1N Hydrochloric acid was added to the reaction mixture, which was subjected to extraction with chloroform.
The organic layer was dried over anhydrous potassium carbonate, and then concentrated under reduced pressure.
The crude product thus obtained was purified by column chromatography (silica gel: 240 g; eluent: hexane.ethyl acetate = 3/1) to obtain the desired product (27) [6.720 g (85.5percent, colorless prisms, m.p. 34 to 34.8°C)].
Reference: [1] Patent: EP278621, 1991, B1,
[2] Patent: US4987130, 1991, A,
  • 6
  • [ 34619-03-9 ]
  • [ 107-11-9 ]
  • [ 78888-18-3 ]
Reference: [1] Organic Letters, 2014, vol. 16, # 15, p. 3998 - 4000
  • 7
  • [ 14370-82-2 ]
  • [ 73210-14-7 ]
  • [ 78888-18-3 ]
Reference: [1] Synthetic Communications, 1984, vol. 14, # 7, p. 605 - 612
[2] Journal of Organic Chemistry, 1986, vol. 51, # 26, p. 5243 - 5252
  • 8
  • [ 4248-19-5 ]
  • [ 14370-82-2 ]
  • [ 78888-18-3 ]
Reference: [1] Journal of Organic Chemistry, 1984, vol. 49, # 19, p. 3647 - 3650
[2] Journal of Organic Chemistry, 1986, vol. 51, # 26, p. 5243 - 5252
  • 9
  • [ 75-09-2 ]
  • [ 107-11-9 ]
  • [ 1070-19-5 ]
  • [ 78888-18-3 ]
Reference: [1] Patent: US4558071, 1985, A,
  • 10
  • [ 79722-21-7 ]
  • [ 78888-18-3 ]
Reference: [1] Journal of Organic Chemistry, 2014, vol. 79, # 4, p. 1620 - 1625
  • 11
  • [ 122148-92-9 ]
  • [ 78888-18-3 ]
Reference: [1] Journal of Organic Chemistry, 2014, vol. 79, # 4, p. 1620 - 1625
  • 12
  • [ 78888-18-3 ]
  • [ 89711-08-0 ]
Reference: [1] Journal of Organic Chemistry, 1988, vol. 53, # 15, p. 3457 - 3465
[2] Journal of Medicinal Chemistry, 1984, vol. 27, # 6, p. 711 - 712
[3] Journal of Medicinal Chemistry, 1986, vol. 29, # 1, p. 104 - 111
[4] Journal of Medicinal Chemistry, 1992, vol. 35, # 6, p. 1067 - 1075
[5] Journal of the American Chemical Society, 2010, vol. 132, # 6, p. 1748 - 1749
[6] Patent: US2002/19527, 2002, A1,
[7] Organic Letters, 2015, vol. 17, # 7, p. 1774 - 1777
[8] Angewandte Chemie - International Edition, 2014, vol. 53, # 41, p. 11075 - 11078
  • 13
  • [ 78888-18-3 ]
  • [ 146231-54-1 ]
Reference: [1] Tetrahedron Letters, 1992, vol. 33, # 48, p. 7281 - 7282
  • 14
  • [ 78888-18-3 ]
  • [ 170384-29-9 ]
Reference: [1] Angewandte Chemie - International Edition, 2010, vol. 49, # 40, p. 7312 - 7315
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 78888-18-3 ]

Alkenes

Chemical Structure| 1807939-98-5

[ 1807939-98-5 ]

tert-Butyl (4-aminobut-2-en-1-yl)carbamate

Similarity: 0.95

Chemical Structure| 1914155-12-6

[ 1914155-12-6 ]

tert-Butyl (4-aminobut-2-en-1-yl)carbamate hydrochloride

Similarity: 0.93

Chemical Structure| 156731-40-7

[ 156731-40-7 ]

1-(Boc-amino)-3-butene

Similarity: 0.90

Chemical Structure| 89985-86-4

[ 89985-86-4 ]

(R)-tert-Butyl (1-hydroxybut-3-en-2-yl)carbamate

Similarity: 0.88

Chemical Structure| 91103-37-6

[ 91103-37-6 ]

(S)-tert-Butyl (1-hydroxybut-3-en-2-yl)carbamate

Similarity: 0.88

Aliphatic Chain Hydrocarbons

Chemical Structure| 1807939-98-5

[ 1807939-98-5 ]

tert-Butyl (4-aminobut-2-en-1-yl)carbamate

Similarity: 0.95

Chemical Structure| 1914155-12-6

[ 1914155-12-6 ]

tert-Butyl (4-aminobut-2-en-1-yl)carbamate hydrochloride

Similarity: 0.93

Chemical Structure| 156731-40-7

[ 156731-40-7 ]

1-(Boc-amino)-3-butene

Similarity: 0.90

Chemical Structure| 38267-76-4

[ 38267-76-4 ]

tert-Butyl ethylcarbamate

Similarity: 0.89

Chemical Structure| 91103-37-6

[ 91103-37-6 ]

(S)-tert-Butyl (1-hydroxybut-3-en-2-yl)carbamate

Similarity: 0.88

Amides

Chemical Structure| 1807939-98-5

[ 1807939-98-5 ]

tert-Butyl (4-aminobut-2-en-1-yl)carbamate

Similarity: 0.95

Chemical Structure| 1914155-12-6

[ 1914155-12-6 ]

tert-Butyl (4-aminobut-2-en-1-yl)carbamate hydrochloride

Similarity: 0.93

Chemical Structure| 156731-40-7

[ 156731-40-7 ]

1-(Boc-amino)-3-butene

Similarity: 0.90

Chemical Structure| 38267-76-4

[ 38267-76-4 ]

tert-Butyl ethylcarbamate

Similarity: 0.89

Chemical Structure| 91103-37-6

[ 91103-37-6 ]

(S)-tert-Butyl (1-hydroxybut-3-en-2-yl)carbamate

Similarity: 0.88

Amines

Chemical Structure| 1807939-98-5

[ 1807939-98-5 ]

tert-Butyl (4-aminobut-2-en-1-yl)carbamate

Similarity: 0.95

Chemical Structure| 1914155-12-6

[ 1914155-12-6 ]

tert-Butyl (4-aminobut-2-en-1-yl)carbamate hydrochloride

Similarity: 0.93

Chemical Structure| 156731-40-7

[ 156731-40-7 ]

1-(Boc-amino)-3-butene

Similarity: 0.90

Chemical Structure| 38267-76-4

[ 38267-76-4 ]

tert-Butyl ethylcarbamate

Similarity: 0.89

Chemical Structure| 91103-37-6

[ 91103-37-6 ]

(S)-tert-Butyl (1-hydroxybut-3-en-2-yl)carbamate

Similarity: 0.88